Novel application of the iCCaRE consortium virtual reality assistant (ViRA) to support Black men at the point of prostate cancer diagnosis
Presenter: Folakemi Odedina, PhD Session: Advances in Survivorship Time: 4/21/2026 2:00:00 PM → 4/21/2026 5:00:00 PM
Authors
Folakemi T. Odedina 1 , Che Ngufor 2 , Christopher Williams 3 , Mary Ellen Young 4 , Floyd Willis 5 , Adam M. Kase 1 , Arnold Merriweather 6 , Emelina Asto-Flores 1 , Dee M. Glaser-Boivin 5 , Jada Melton 1 , Monica L. Albertie 7 , Michelle Fudge 1 , Quincy Wimberly 1 , Inclusive Cancer Care Research Equity (iCCaRE) Consortium , Prostate Cancer Transatlantic Consortium (CaPTC) 1 Mayo Clinic Florida, Jacksonville, FL, 2 Mayo Clinic, Rochester, MN, 3 Urological Assoc Inc, Jacksonville, FL, 4 University of Florida College of Public Health & Health Professions, Gainesville, FL, 5 Mayo Clinic, Jacksonville, FL, 6 Black Male Prostate Coalition of Florida, Jacksonville, FL, 7 Cancer Services, Mayo Clinic, Jacksonville, FL
Abstract
Background: Black men carry a disproportionate prostate cancer (CaP) burden and often experience significant psychosocial distress at the point of prostate cancer diagnosis (PPCD). Many report emotional shock, uncertainty, and limited access to culturally competent guidance, which can negatively affect treatment decisions and long-term survivorship. To address these needs, we developed the PPCD Virtual Reality Assistant (ViRA), an immersive, AI-enabled intervention co-designed with Black CaP survivors. ViRA delivers tailored psycho-oncology support, emotional guidance, and navigation of social determinants of health (SDOH) within virtual reality environments. This study evaluated the feasibility, acceptability, and usability of the PPCD ViRA (NCT06535802). Methods: ViRA was developed through a structured, seven-step co-design process with survivors, integrating mobile immersive technologies, SDOH navigation, and culturally grounded psycho-oncology content. Personalization was enabled through AI-driven predictive analytics and a recommendation engine. Alpha testing assessed initial usability and acceptability among 10 participants (seven team members and three Black CaP survivors). Beta testing with 24 Black men in Florida examined feasibility and preliminary efficacy. Results: A demonstration of ViRA is available (https://www.youtube.com/watch?v=1mI-HS5R6sk). Alpha testing indicated strong usability, positive emotional engagement, and clear promise for enhancing support at the PPCD. In Beta testing, participants varied in age; most were married (58.3%), held a bachelor’s degree (45.8%), were retired (45.8%), and had a family history of cancer (83.3%). ViRA use was associated with increased engagement and reduced distress across participants. Overall, 74% rated ViRA as “excellent,” while the remainder rated it as “good” or “very good.” More than 90% reported being “very satisfied,” with the rest indicating satisfaction. Conclusions: Findings demonstrate high feasibility, acceptability, and cultural relevance of the PPCD ViRA for supporting Black men at diagnosis. Lessons learned highlight the need for culturally embedded design, emotional timing, community co-creation, flexible delivery formats, and strong community partnerships to advance digital health equity. The refinement and larger-scale validation to establish clinical utility and readiness for implementation is ongoing (NCT07126548).
Disclosure
F. T. Odedina, None.. C. Williams, None.. J. Melton, None.. M. Fudge, None.. Q. Wimberly, None.
Cited in
Control: 7275 · Presentation Id: 1057 · Meeting 21436